{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:47:06Z","timestamp":1793965626005,"version":"4.8.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005187","name":"National and Kapodistrian University of Athens","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005187","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.eururo.2022.01.045","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T04:02:42Z","timestamp":1645588962000},"page":"49-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":346,"title":["European Association of Urology Guidelines on the Diagnosis and Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 1: Diagnostics, Overactive Bladder, Stress Urinary Incontinence, and Mixed Urinary Incontinence"],"prefix":"10.1016","volume":"82","author":[{"given":"Arjun K.","family":"Nambiar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Arlandis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"B\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanny","family":"Cobussen-Boekhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Costantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"de Heide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawzy","family":"Farag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Groen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markos","family":"Karavitakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Carmela","family":"Lapitan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Manso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serenella Monagas","family":"Arteaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling Nic An","family":"Riogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eabhann","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Imran","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Peyronnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Ph\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios I.","family":"Sakalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00e9ha","family":"Sihra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazaros","family":"Tzelves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Lynne","family":"van Poelgeest-Pomfret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine W.L.","family":"van den Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huub","family":"van der Vaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher K.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2022.01.045_b0005","series-title":"EAU guidelines on urinary incontinence in adults","author":"Burkhard","year":"2017"},{"key":"10.1016\/j.eururo.2022.01.045_b0010","series-title":"EAU guidelines: non-neurogenic female lower urinary tract symptoms","author":"Harding","year":"2021"},{"key":"10.1016\/j.eururo.2022.01.045_b0015","series-title":"FDA guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims","author":"US Department of Health and Human Services","year":"2009"},{"key":"10.1016\/j.eururo.2022.01.045_b0020","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00192-012-1925-6","article-title":"Women\u2019s ability to assess their urinary incontinence type using the QUID as an educational tool","volume":"24","author":"Farrell","year":"2013","journal-title":"Int Urogynecol J"},{"issue":"244","key":"10.1016\/j.eururo.2022.01.045_b0025","first-page":"e1","article-title":"Long-term efficacy and safety of questionnaire-based initiation of urgency urinary incontinence treatment","volume":"209","author":"Hess","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.eururo.2022.01.045_b0030","series-title":"International Consultation on Incontinence Questionnaire Female Lower Urinary Tract Symptoms Modules (ICIQ-FLUTS)","author":"ICIQ Development Group","year":"2014"},{"key":"10.1016\/j.eururo.2022.01.045_b0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.01.045_b0040","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/nau.21036","volume":"30","author":"Haylen","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.01.045_b0045","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0090-4295(02)02505-0","article-title":"Measurement characteristics of a voiding diary for use by men and women with overactive bladder","volume":"61","author":"Brown","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2022.01.045_b0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/PL00004021","article-title":"Reproducibility of the seven-day voiding diary in women with stress urinary incontinence","volume":"11","author":"Nygaard","year":"2000","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.eururo.2022.01.045_b0055","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.eururo.2014.02.057","article-title":"Developing and validating the International Consultation on Incontinence Questionnaire bladder diary","volume":"66","author":"Bright","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.01.045_b0060","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/nau.22530","article-title":"The 3-day bladder diary is a feasible, reliable and valid tool to evaluate the lower urinary tract symptoms in women","volume":"34","author":"Jimenez-Cidre","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.01.045_b0065","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1001\/jama.280.23.1995","article-title":"Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial","volume":"280","author":"Burgio","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2022.01.045_b0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.archger.2011.07.012","article-title":"Clinical presentation of urinary tract infection (UTI) differs with aging in women","volume":"55","author":"Arinzon","year":"2012","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.eururo.2022.01.045_b0075","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00192-004-1192-2","article-title":"Utility of urine reagent strip in screening women with incontinence for urinary tract infection","volume":"15","author":"Buchsbaum","year":"2004","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.eururo.2022.01.045_b0080","doi-asserted-by":"crossref","first-page":"749","DOI":"10.7326\/0003-4819-122-10-199505150-00003","article-title":"Does eradicating bacteriuria affect the severity of chronic urinary incontinence in nursing home residents?","volume":"122","author":"Ouslander","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eururo.2022.01.045_b0085","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1464-410x.1999.00121.x","article-title":"Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function","volume":"84","author":"Abrams","year":"1999","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2022.01.045_b0090","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003195.pub3","article-title":"Urodynamic studies for management of urinary incontinence in children and adults","author":"Clement","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eururo.2022.01.045_b0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/1471-0528.12954","article-title":"Does preoperative urodynamics improve outcomes for women undergoing surgery for stress urinary incontinence? A systematic review and meta-analysis","volume":"122","author":"Rachaneni","year":"2015","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.eururo.2022.01.045_b0100","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1113595","article-title":"A randomized trial of urodynamic testing before stress-incontinence surgery","volume":"366","author":"Nager","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2022.01.045_b0105","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.juro.2011.03.105","article-title":"Baseline urodynamic predictors of treatment failure 1 year after mid urethral sling surgery","volume":"186","author":"Nager","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.01.045_b0110","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1464-410X.2009.09037.x","article-title":"Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity","volume":"105","author":"Nitti","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2022.01.045_b0115","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/nau.21021","article-title":"Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder","volume":"30","author":"Rovner","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.01.045_b0120","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/S0022-5347(17)32311-X","article-title":"Predictors of success with neuromodulation in lower urinary tract dysfunction: results of trial stimulation in 100 patients","volume":"152","author":"Koldewijn","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.01.045_b0125","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00192-007-0351-7","article-title":"Detrusor overactivity does not predict outcome of sacral neuromodulation test stimulation","volume":"18","author":"South","year":"2007","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.eururo.2022.01.045_b0130","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.eururo.2004.07.013","article-title":"Pelvicol pubovaginal sling versus tension-free vaginal tape for treatment of urodynamic stress incontinence: a prospective randomized three-year follow-up study","volume":"46","author":"Abdel-Fattah","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.01.045_b0135","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.juro.2008.07.027","article-title":"Normal preoperative urodynamic testing does not predict voiding dysfunction after Burch colposuspension versus pubovaginal sling","volume":"180","author":"Lemack","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.01.045_b0140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/nau.10162","article-title":"The association between overactive bladder symptoms and objective parameters from bladder diary and filling cystometry","volume":"23","author":"van Brummen","year":"2004","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.01.045_b0145","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00192-011-1568-z","article-title":"Normal lower urinary tract assessment in women: I. Uroflowmetry and post-void residual, pad tests, and bladder diaries","volume":"23","author":"Al Afraa","year":"2012","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.eururo.2022.01.045_b0150","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/nau.22436","article-title":"Pad weight testing in the evaluation of urinary incontinence","volume":"33","author":"Krhut","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.01.045_b0155","series-title":"Incontinence, 6th ed.","first-page":"671","article-title":"Imaging, neurophysiological testing and other tests","author":"Khullar","year":"2017"},{"key":"10.1016\/j.eururo.2022.01.045_b0160","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MOU.0000000000000064","article-title":"Biomarkers in lower urinary tract symptoms\/overactive bladder: a critical overview","volume":"24","author":"Antunes-Lopes","year":"2014","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.eururo.2022.01.045_b0165","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1479-828X.2009.01070.x","article-title":"Is detrusor hypertrophy in women associated with voiding dysfunction?","volume":"49","author":"Lekskulchai","year":"2009","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.eururo.2022.01.045_b0170","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1148\/radiol.2492072009","article-title":"Reproducibility of dynamic MR imaging pelvic measurements: a multi-institutional study","volume":"249","author":"Lockhart","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.eururo.2022.01.045_b0175","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/nau.20798","article-title":"An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction","volume":"29","author":"Haylen","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.01.045_b0180","first-page":"45","article-title":"Absorbent products for containing urinary and\/or fecal incontinence in adults","volume":"29","author":"Brazzelli","year":"2002","journal-title":"J Wound Ostomy Continence Nurs"},{"key":"10.1016\/j.eururo.2022.01.045_b0185","series-title":"Catheterisation. Indwelling catheters in adults \u2013 urethral and suprapubic \u2013 evidence-based guidelines for best practice in urological health care","author":"Geng","year":"2012"},{"key":"10.1016\/j.eururo.2022.01.045_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-9056(14)60751-X","article-title":"Catheter designs, techniques and strategies for intermittent catheterisation: what is the evidence for preventing symptomatic UTI and other complications? A Cochrane systematic review","volume":"13","author":"Prieto","year":"2014","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.eururo.2022.01.045_b0195","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/nau.24344","article-title":"What do we really know about the role of caffeine on urinary tract symptoms? A scoping review on caffeine consumption and lower urinary tract symptoms in adults","volume":"39","author":"Le Berre","year":"2020","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.01.045_b0200","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1464-410X.2008.07463.x","article-title":"How should patients with an overactive bladder manipulate their fluid intake?","volume":"102","author":"Hashim","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2022.01.045_b0205","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1111\/j.1464-410X.2009.09055.x","article-title":"Urinary Incontinence Treatment Network. Effect of fluid management on fluid intake and urge incontinence in a trial for overactive bladder in women","volume":"105","author":"Zimmern","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2022.01.045_b0210","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.soard.2008.10.006","article-title":"Obesity is associated with increased prevalence and severity of pelvic floor disorders in women considering bariatric surgery","volume":"5","author":"Chen","year":"2009","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.eururo.2022.01.045_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14400","article-title":"Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence","volume":"14","author":"Imamura","year":"2010","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.eururo.2022.01.045_b0220","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002113","article-title":"Prompted voiding for the management of urinary incontinence in adults","author":"Eustice","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eururo.2022.01.045_b0225","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1447-0594.2012.00875.x","article-title":"Systematic review of care intervention studies for the management of incontinence and promotion of continence in older people in care homes with urinary incontinence as the primary focus (1966\u20132010)","volume":"12","author":"Flanagan","year":"2012","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.eururo.2022.01.045_b0230","doi-asserted-by":"crossref","unstructured":"NICE guidance \u2013 urinary incontinence and pelvic organ prolapse in women: management. BJU Int 2019;123:777\u2013803. https:\/\/doi.org\/10.1111\/bju.14763.","DOI":"10.1111\/bju.14763"},{"key":"10.1016\/j.eururo.2022.01.045_b0235","series-title":"Nonsurgical treatments for urinary incontinence in adult women: diagnosis and comparative effectiveness","author":"Shamliyan","year":"2012"},{"key":"10.1016\/j.eururo.2022.01.045_b0240","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.physio.2019.08.011","article-title":"Is pelvic floor muscle training effective for symptoms of overactive bladder in women? A systematic review","volume":"106","author":"Bo","year":"2020","journal-title":"Physiotherapy"},{"key":"10.1016\/j.eururo.2022.01.045_b0245","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.juro.2010.06.113","article-title":"Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial","volume":"184","author":"Finazzi-Agro","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.01.045_b0250","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.juro.2009.12.036","article-title":"Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial","volume":"183","author":"Peters","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.01.045_b0255","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/nau.23893","article-title":"Which anticholinergic is best for people with overactive bladders? A network meta-analysis","volume":"38","author":"Herbison","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.01.045_b0260","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/bju.12678","article-title":"Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial","volume":"114","author":"Chapple","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2022.01.045_b0265","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/ijcp.12464","article-title":"Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ER","volume":"68","author":"Kaplan","year":"2014","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.eururo.2022.01.045_b0270","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/nau.22505","article-title":"Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability","volume":"33","author":"Chapple","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.01.045_b0275","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11255-013-0509-9","article-title":"The efficacy and safety of mirabegron in treating OAB: a systematic review and meta-analysis of phase III trials","volume":"46","author":"Cui","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.eururo.2022.01.045_b0280","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000361079","article-title":"The role of mirabegron in overactive bladder: a systematic review and meta-analysis","volume":"93","author":"Wu","year":"2014","journal-title":"Urol Int"},{"key":"10.1016\/j.eururo.2022.01.045_b0285","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.eururo.2013.11.010","article-title":"Comparative efficacy and safety of medical treatments for the management of overactive bladder: a systematic literature review and mixed treatment comparison","volume":"65","author":"Maman","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.01.045_b0290","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.juro.2016.03.174","article-title":"Mirabegron as add-on treatment to solifenacin in patients with incontinent overactive bladder and an inadequate response to solifenacin monotherapy","volume":"196","author":"MacDiarmid","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.01.045_b0295","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jalz.2012.02.005","article-title":"Long-term anticholinergic use and the aging brain","volume":"9","author":"Cai","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.eururo.2022.01.045_b0300","first-page":"225","article-title":"The cognitive impact of anticholinergics: a clinical review","volume":"4","author":"Campbell","year":"2009","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.eururo.2022.01.045_b0305","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/nau.23508","article-title":"An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for the assessment of sexual health of women with pelvic floor dysfunction","volume":"37","author":"Rogers","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.01.045_b0310","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/GME.0000000000001221","article-title":"A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause","volume":"26","author":"Biehl","year":"2019","journal-title":"Menopause"},{"key":"10.1016\/j.eururo.2022.01.045_b0315","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa1208872","article-title":"Anticholinergic therapy vs. onabotulinumtoxinA for urgency urinary incontinence","volume":"367","author":"Visco","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2022.01.045_b0320","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/bju.13945","article-title":"Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis","volume":"120","author":"Drake","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2022.01.045_b0325","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.eururo.2017.11.002","article-title":"Efficacy and safety of sacral and percutaneous tibial neuromodulation in non-neurogenic lower urinary tract dysfunction and chronic pelvic pain: a systematic review of the literature","volume":"73","author":"Tutolo","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.01.045_b0330","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.juro.2007.07.032","article-title":"Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study","volume":"178","author":"van Kerrebroeck","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.01.045_b0335","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/jama.2016.14617","article-title":"OnabotulinumtoxinA vs sacral neuromodulation on refractory urgency urinary incontinence in women: a randomized clinical trial","volume":"316","author":"Amundsen","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2022.01.045_b0340","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.eururo.2018.02.011","article-title":"Two-year outcomes of sacral neuromodulation versus onabotulinumtoxinA for refractory urgency urinary incontinence: a randomized trial","volume":"74","author":"Amundsen","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.01.045_b0345","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1464-410x.1998.00549.x","article-title":"Long-term results and complications of augmentation ileocystoplasty for idiopathic urge incontinence in women","volume":"81","author":"Awad","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2022.01.045_b0350","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/nau.22775","article-title":"Risk of malignancy after augmentation cystoplasty: a systematic review","volume":"35","author":"Biardeau","year":"2016","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.01.045_b0355","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005654.pub4","article-title":"Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women","author":"Dumoulin","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eururo.2022.01.045_b0360","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001405.pub3","article-title":"Oestrogen therapy for urinary incontinence in post-menopausal women","author":"Cody","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eururo.2022.01.045_b0365","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11255-013-0410-6","article-title":"The role of duloxetine in stress urinary incontinence: a systematic review and meta-analysis","volume":"45","author":"Li","year":"2013","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.eururo.2022.01.045_b0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta23140","article-title":"Surgical treatments for women with stress urinary incontinence: the ESTER systematic review and economic evaluation","volume":"23","author":"Brazzelli","year":"2019","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.eururo.2022.01.045_b0375","first-page":"CD002912","article-title":"Open retropubic colposuspension for urinary incontinence in women","volume":"2016","author":"Lapitan","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eururo.2022.01.045_b0380","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00192-012-1825-9","article-title":"A systematic review and meta-analysis of Macroplastique for treating female stress urinary incontinence","volume":"24","author":"Ghoniem","year":"2013","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.eururo.2022.01.045_b0385","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/JU.0000000000000517","article-title":"Tension-free vaginal tape surgery versus polyacrylamide hydrogel injection for primary stress urinary incontinence: a randomized clinical trial","volume":"203","author":"Itkonen Freitas","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.01.045_b0390","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00192-013-2058-2","article-title":"Long-term follow-up of the retropubic tension-free vaginal tape procedure","volume":"24","author":"Svenningsen","year":"2013","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.eururo.2022.01.045_b0395","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/bju.12851","article-title":"Long-term follow-up of a multicentre randomised controlled trial comparing tension-free vaginal tape, xenograft and autologous fascial slings for the treatment of stress urinary incontinence in women","volume":"115","author":"Khan","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2022.01.045_b0400","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.urology.2019.03.003","article-title":"Transobturator tape: over 10 years follow-up","volume":"129","author":"Natale","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2022.01.045_b0405","first-page":"78","article-title":"Diagnosis, evaluation, and treatment of mixed urinary incontinence in women","volume":"17","author":"Chughtai","year":"2015","journal-title":"Rev Urol"},{"key":"10.1016\/j.eururo.2022.01.045_b0410","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00192-014-2517-4","article-title":"Short-term effect of adding pelvic floor muscle training to bladder training for female urinary incontinence: a randomized controlled trial","volume":"26","author":"Kaya","year":"2015","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.eururo.2022.01.045_b0415","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.urology.2004.02.029","article-title":"Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial","volume":"64","author":"Khullar","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2022.01.045_b0420","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1046\/j.1464-410X.2003.04363.x","article-title":"Tolterodine is equally effective in patients with mixed incontinence and those with urge incontinence alone","volume":"92","author":"Kreder","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2022.01.045_b0425","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00192-005-0023-4","article-title":"Solifenacin: as effective in mixed urinary incontinence as in urge urinary incontinence","volume":"17","author":"Kelleher","year":"2006","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.eururo.2022.01.045_b0430","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/nau.20471","article-title":"Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence","volume":"27","author":"Bent","year":"2008","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.01.045_b0435","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.juro.2007.10.074","article-title":"Predictors of treatment failure 24 months after surgery for stress urinary incontinence","volume":"179","author":"Richter","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.01.045_b0440","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/AOG.0b013e31820f3892","article-title":"Demographic and clinical predictors of treatment failure one year after midurethral sling surgery","volume":"117","author":"Richter","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.eururo.2022.01.045_b0445","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00192-007-0449-y","article-title":"Follow-up of TVT operations in 1,113 women with mixed urinary incontinence at 7 and 38 months","volume":"19","author":"Kulseng-Hanssen","year":"2008","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.eururo.2022.01.045_b0450","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s00192-016-3031-7","article-title":"Methods for a multicenter randomized trial for mixed urinary incontinence: rationale and patient-centeredness of the ESTEEM trial","volume":"27","author":"Sung","year":"2016","journal-title":"Int Urogynecol J"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283822016037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283822016037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:11:56Z","timestamp":1759583516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283822016037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0302283822016037"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2022.01.045","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"European Association of Urology Guidelines on the Diagnosis and Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 1: Diagnostics, Overactive Bladder, Stress Urinary Incontinence, and Mixed Urinary Incontinence","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2022.01.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2022.01.044","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}